Total Payments
$1,645
2024 Payments
$15.07
Companies
15
Transactions
78
Medicare Patients
2,911
Medicare Billing
$485,414
Payment Breakdown by Category
Food & Beverage$1,185 (72.0%)
Education$460.37 (28.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,185 | 71 | 72.0% |
| Education | $460.37 | 7 | 28.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Insmed, Inc. | $314.75 | 13 | $0 (2023) |
| Merck Sharp & Dohme LLC | $269.88 | 17 | $0 (2023) |
| Gilead Sciences, Inc. | $251.31 | 17 | $0 (2024) |
| Astellas Pharma US Inc | $184.44 | 3 | $0 (2021) |
| Janssen Products, LP | $131.44 | 2 | $0 (2022) |
| ViiV Healthcare Company | $94.21 | 6 | $0 (2023) |
| La Jolla Pharmaceutical Company | $88.65 | 5 | $0 (2023) |
| PFIZER INC. | $84.31 | 5 | $0 (2023) |
| Janssen Biotech, Inc. | $63.11 | 2 | $0 (2023) |
| TETRAPHASE PHARMACEUTICALS, INC. | $38.72 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.07 | 1 | Gilead Sciences, Inc. ($15.07) |
| 2023 | $369.55 | 18 | Merck Sharp & Dohme LLC ($64.42) |
| 2022 | $351.26 | 19 | Merck Sharp & Dohme LLC ($60.84) |
| 2021 | $191.40 | 9 | Astellas Pharma US Inc ($85.44) |
| 2020 | $29.69 | 2 | Merck Sharp & Dohme Corporation ($15.19) |
| 2019 | $330.12 | 15 | Insmed, Inc. ($208.90) |
| 2018 | $160.19 | 6 | Astellas Pharma US Inc ($99.00) |
| 2017 | $197.61 | 8 | Janssen Products, LP ($99.95) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 2 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/24/2022 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), ISENTRESS, DIFICID | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/08/2022 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 08/03/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: HIV | ||||||
| 06/17/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.33 | General |
| 06/15/2022 | Smith+Nephew, Inc. | STRAVIX (Medical Supply) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Extremities & Limb Restoration | ||||||
| 06/03/2022 | PFIZER INC. | PANZYGA (Biological), CUTAQUIG | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 05/18/2022 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), ISENTRESS, DELSTRIGO | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/04/2022 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 04/27/2022 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 04/06/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, RECARBRIO | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/23/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Respiratory | ||||||
| 03/21/2022 | Janssen Products, LP | SYMTUZA (Drug) | Education | In-kind items and services | $31.49 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 02/23/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.09 | General |
| 11/02/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $64.99 | General |
| 10/06/2021 | VYERA PHARMACEUTICALS, LLC | Daraprim (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Toxoplasmosis | ||||||
| 09/15/2021 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: HOSPITAL AND TRANSPLANT | ||||||
| 08/18/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.75 | General |
| 08/11/2021 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: IMMUNOLOGY | ||||||
| 06/14/2021 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Respiratory | ||||||
| 03/31/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.15 | General |
| 03/17/2021 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Respiratory | ||||||
| 02/10/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.65 | General |
| 02/10/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.50 | General |
| 01/22/2020 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), PIFELTRO, DIFICID | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/17/2019 | TETRAPHASE PHARMACEUTICALS, INC. | Xerava (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Complicated Intra-Abdominal Infections | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 599 | 1,294 | $180,366 | $97,307 |
| 2022 | 5 | 642 | 1,458 | $207,379 | $108,839 |
| 2021 | 6 | 803 | 1,860 | $265,619 | $140,544 |
| 2020 | 6 | 867 | 1,878 | $253,331 | $138,723 |
Total Patients
2,911
Total Services
6,490
Medicare Billing
$485,414
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 225 | 711 | $73,944 | $42,234 | 57.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 193 | 217 | $42,966 | $21,287 | 49.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 79 | 225 | $33,525 | $19,663 | 58.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 111 | $21,201 | $10,174 | 48.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 30 | $8,730 | $3,949 | 45.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 220 | 703 | $73,112 | $38,667 | 52.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 117 | 389 | $57,961 | $30,785 | 53.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 185 | 200 | $39,600 | $20,753 | 52.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 116 | $22,156 | $11,101 | 50.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 49 | 50 | $14,550 | $7,533 | 51.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 156 | 625 | $93,125 | $50,499 | 54.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 259 | 803 | $83,426 | $44,212 | 53.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 233 | 244 | $48,312 | $24,840 | 51.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 70 | 70 | $20,370 | $10,563 | 51.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 82 | $15,662 | $8,207 | 52.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 36 | $4,724 | $2,223 | 47.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 329 | 997 | $102,691 | $57,005 | 55.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 130 | 421 | $62,729 | $34,766 | 55.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 240 | 257 | $50,886 | $27,707 | 54.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 62 | 64 | $18,624 | $10,195 | 54.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 48 | 65 | $10,335 | $5,032 | 48.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 58 | 74 | $8,066 | $4,018 | 49.8% |
About Dr. Arlette Aouad, M.D
Dr. Arlette Aouad, M.D is a Infectious Disease healthcare provider based in Toledo, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1447241880.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arlette Aouad, M.D has received a total of $1,645 in payments from pharmaceutical and medical device companies, with $15.07 received in 2024. These payments were reported across 78 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,185).
As a Medicare-enrolled provider, Aouad has provided services to 2,911 Medicare beneficiaries, totaling 6,490 services with total Medicare billing of $485,414. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Toledo, OH
- Active Since 11/03/2005
- Last Updated 10/17/2012
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1447241880
Products in Payments
- Arikayce (Drug) $314.75
- PREZCOBIX (Drug) $99.95
- SYMTUZA (Drug) $94.60
- DOVATO (Drug) $94.21
- XERAVA (Drug) $88.65
- PIFELTRO (Drug) $75.88
- ZERBAXA (Drug) $59.55
- NOXAFIL (Drug) $52.34
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $50.69
- Xerava (Drug) $38.72
- ISENTRESS (Drug) $34.25
- Hillrom - Life 2000 Ventilation System (Device) $34.06
- PANZYGA (Biological) $33.62
- DIFICID (Drug) $24.52
- CRESEMBA (Drug) $20.45
- REBYOTA (Biological) $20.27
- STRAVIX (Medical Supply) $19.28
- Daraprim (Drug) $15.68
- CUBICIN RF (Drug) $11.71
- SIVEXTRO (Drug) $11.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Toledo
Tanyanyiwa Chinyadza, M.d, M.D
Infectious Disease — Payments: $7,405
Infectious Disease $7,405
Dr. Luis Jauregui, M.d, M.D
Infectious Disease — Payments: $354.92
Infectious Disease $354.92
Dr. Caitlyn Hollingshead, Md, MD
Infectious Disease — Payments: $332.90
Infectious Disease $332.90
Razi Syed, Md, MD
Infectious Disease — Payments: $283.43
Infectious Disease $283.43
Michael Ellis, M.d, M.D
Infectious Disease — Payments: $85.64
Infectious Disease $85.64
Dr. Haig Donabedian, M.d, M.D
Infectious Disease
Infectious Disease